Skip to main content

Apis Capital Advisors, LLC

SEC CIK
0001386892
Latest filing
Aug 14, 2026

AMAM holding history

Ambrx Biopharma, Inc. in every 13F filed by Apis Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMAM overviewAll 13F holders of AMAMFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q2 2023
Holdings of AMAM by Apis Capital Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−34,000−100.0%Sold outHolders
Q3 202334,000$391.0K0.5%00.0%UnchangedHolders
Q2 202334,000$559.6K0.6%+34,000NewHolders